Merck KGaA, Pfizer’s immuno-drug shown to alleviate kidney cancer
FRANKFURT (Reuters) – Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer when used in combination with Pfizer’s Inlyta drug in a…